A detailed history of Invesco Ltd. transactions in Insmed Inc stock. As of the latest transaction made, Invesco Ltd. holds 1,062,395 shares of INSM stock, worth $78.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,062,395
Previous 756,241 40.48%
Holding current value
$78.5 Million
Previous $50.7 Million 53.06%
% of portfolio
0.02%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$62.0 - $79.01 $19 Million - $24.2 Million
306,154 Added 40.48%
1,062,395 $77.6 Million
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $13 Million - $41 Million
588,678 Added 351.32%
756,241 $50.7 Million
Q1 2024

May 14, 2024

BUY
$25.72 - $29.94 $1.7 Million - $1.98 Million
66,039 Added 65.05%
167,563 $4.55 Million
Q4 2023

Feb 12, 2024

SELL
$23.42 - $31.74 $8,524 - $11,553
-364 Reduced 0.36%
101,524 $3.15 Million
Q3 2023

Nov 13, 2023

SELL
$19.86 - $26.93 $5,799 - $7,863
-292 Reduced 0.29%
101,888 $2.57 Million
Q2 2023

Aug 11, 2023

SELL
$16.44 - $21.1 $28,868 - $37,051
-1,756 Reduced 1.69%
102,180 $2.16 Million
Q1 2023

May 12, 2023

BUY
$16.26 - $21.73 $162,843 - $217,625
10,015 Added 10.66%
103,936 $1.77 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $347,037 - $473,139
20,438 Added 27.81%
93,921 $1.88 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $128,349 - $173,406
6,147 Added 9.13%
73,483 $1.58 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $24,341 - $36,662
1,426 Added 2.16%
67,336 $1.33 Million
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $114,474 - $157,696
5,606 Added 9.3%
65,910 $1.55 Million
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $37,411 - $48,335
-1,445 Reduced 2.34%
60,304 $1.64 Million
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $12.8 Million - $16.7 Million
-567,866 Reduced 90.19%
61,749 $1.7 Million
Q2 2021

Aug 17, 2021

SELL
$24.17 - $36.01 $13.4 Million - $20 Million
-554,507 Reduced 46.83%
629,615 $17.9 Million
Q1 2021

May 17, 2021

BUY
$32.28 - $44.3 $16.4 Million - $22.5 Million
507,609 Added 75.03%
1,184,122 $40.3 Million
Q4 2020

Feb 16, 2021

BUY
$31.45 - $40.54 $13.1 Million - $16.9 Million
416,620 Added 160.3%
676,513 $22.5 Million
Q3 2020

Nov 16, 2020

BUY
$26.0 - $34.5 $5.83 Million - $7.74 Million
224,220 Added 628.54%
259,893 $8.35 Million
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $318,279 - $663,626
22,557 Added 171.98%
35,673 $983,000
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $11,435 - $28,509
-839 Reduced 6.01%
13,116 $210,000
Q4 2019

Feb 14, 2020

SELL
$16.12 - $24.98 $14,636 - $22,681
-908 Reduced 6.11%
13,955 $333,000
Q3 2019

Nov 14, 2019

SELL
$15.49 - $25.78 $8,922 - $14,849
-576 Reduced 3.73%
14,863 $262,000
Q2 2019

Aug 14, 2019

SELL
$23.0 - $32.19 $763,945 - $1.07 Million
-33,215 Reduced 68.27%
15,439 $395,000
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $676,777 - $1.52 Million
48,654 New
48,654 $1.41 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.